Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Stem Cell Transplant”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT00342134
What this trial is testing

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 34
Large-scale testing (Phase 3)Active Not RecruitingNCT03477500
What this trial is testing

Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)

Who this might be right for
Multiple Sclerosis
Haukeland University Hospital 100
Early research (Phase 1)Ended earlyNCT04203017
What this trial is testing

Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT00716066
What this trial is testing

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Who this might be right for
Autoimmune DiseaseNeurologic Autoimmune DiseaseAutologous Transplant Autoimmune+16 more
Fred Hutchinson Cancer Center 53
Not applicableUnknownNCT04674280
What this trial is testing

Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Sclerosis
European Society for Blood and Marrow Transplantation 50
Early research (Phase 1)Looking for participantsNCT05832515
What this trial is testing

AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
St. Petersburg State Pavlov Medical University 200
Testing effectiveness (Phase 2)Study completedNCT01099930
What this trial is testing

Autologous Stem Cell Transplant for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Ottawa Hospital Research Institute 24
Early research (Phase 1)Study completedNCT00014755
What this trial is testing

Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fred Hutchinson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT01413100
What this trial is testing

Scleroderma Treatment With Autologous Transplant (STAT) Study

Who this might be right for
Systemic Scleroderma
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00040482
What this trial is testing

High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Baylor College of Medicine 10
Early research (Phase 1)UnknownNCT03069170
What this trial is testing

Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis
Stem Cells Arabia 50
Testing effectiveness (Phase 2)Study completedNCT00288626
What this trial is testing

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)UnknownNCT03113162
What this trial is testing

Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Makati Medical Center 15
Not applicableLooking for participantsNCT06218927
What this trial is testing

The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients

Who this might be right for
Multiple SclerosisLower Urinary Tract Symptoms
University Hospital Ostrava 40
Not applicableStudy completedNCT02601131
What this trial is testing

Post-transfusion Platelet Count

Who this might be right for
LeukemiaMultiple Sclerosis
Region Skane 80
Not applicableLooking for participantsNCT06195800
What this trial is testing

Biomarkers of aHSCT

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Sheffield Teaching Hospitals NHS Foundation Trust 15
Not applicableStudy completedNCT05029206
What this trial is testing

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Uppsala University 174
Early research (Phase 1)Study completedNCT03269071
What this trial is testing

Neural Stem Cell Transplantation in Multiple Sclerosis Patients

Who this might be right for
Progressive Multiple Sclerosis
IRCCS San Raffaele 4
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Not applicableUnknownNCT02674217
What this trial is testing

Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells

Who this might be right for
Multiple Sclerosis
Centro de Hematología y Medicina Interna 1,000
Load More Results